Study S001297

Unicenter Interventional Study Aimed at Improving the Quality of Life in a Group of Very Old Patients With Type 2 Diabetes With Fixed-ratio Combination of Insulin Degludec and Liraglutide (iDegLira)

ClinicalTrials.gov record

Registration

Registration: NCT04190160
Acronym: XETD2
Study type: INTERVENTIONAL
Masking: NONE
Status: COMPLETED
Enrollment: 35
Start: 2018-11-19
Primary completion: 2019-11-22
Lead sponsor: Stefano Rizza
Conditions: Type2 Diabetes
Interventions: DRUG:IDegLira
Results posted: FALSE

Registered primary outcomes

Self reported quality of Life (CASP-19) [6 months]
The Diabetes Treatment Satisfaction (DTSQ) [6 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.